Loading clinical trials...
Loading clinical trials...
A Phase II, Single-Arm, Open-Label, Multicenter Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
Conditions
Interventions
Hydronidone capsules
Locations
1
China
Chongqing Medical University Second Affiliated Hospital
Chongqing, Chongqing Municipality, China
Start Date
April 14, 2026
Primary Completion Date
July 30, 2026
Completion Date
July 30, 2026
Last Updated
April 24, 2026
Lead Sponsor
Beijing Continent Pharmaceutical Co, Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions